Understanding the Class Action Against Applied Therapeutics (APLT)
Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT)
Investors of Applied Therapeutics, Inc. may want to pay close attention to some recent developments regarding a class action lawsuit filed against the company. This lawsuit comes as Applied Therapeutics, known for its work in drug development, faces serious allegations that could affect its stocks and reputation.
Overview of the Class Action
The class action lawsuit, initiated by Levi & Korsinsky, LLP, aims to recover damages for shareholders who allegedly suffered losses due to potential securities fraud impacting the company within a specified timeframe. Investors who held shares of Applied Therapeutics during this period could be eligible to join this class action.
Time Period of Allegations
The lawsuit surrounds events that transpired from early January to late December of the previous year. Allegations center on claims of misrepresentation and failures to inform investors adequately about the state of their lead drug candidate, leading to significant financial losses for shareholders.
Legal Details
The complaint points to a pivotal announcement made by the company on a particular day in November. Applied Therapeutics issued a press release stating they received a Complete Response Letter (CRL) from the FDA regarding their New Drug Application for govorestat. This document serves as a major indicator of the potential viability of their drug.
Impact on Stock Prices
Following the unfortunate news regarding the CRL, Applied Therapeutics saw a steep decline in its stock value. This share price nosedive has been a significant point of concern for investors, with losses surpassing 80% from its previous closing price, marking a troubling time for the company’s stakeholders.
Your Rights as an Investor
If you hold shares of Applied Therapeutics and faced losses during the specified timeframe, it's essential to be informed about your rights. You have until a stated deadline to be considered as a lead plaintiff in this action. However, it’s crucial to note that participating in the class action doesn't necessitate that you take on the lead plaintiff role to secure potential compensation.
No Out-of-Pocket Costs
One reassuring aspect of the class action is that members typically do not need to pay any up-front fees. If the lawsuit is successful, costs are often covered from the recovery amounts, making it accessible for many investors who may not have the resources to engage in litigation independently.
Choosing Trustworthy Legal Representation
In a landscape fraught with uncertainties regarding securities litigation, it's important to choose a firm with a proven track record. Levi & Korsinsky boasts over two decades of experience in securities litigation, focusing on protecting the rights of shareholders. Their reputation as one of the top firms in this specialty could provide assurance to investors considering their options.
Contact Information for Assistance
For those wishing to learn more about the class action or to get involved, Levi & Korsinsky offers contact options. Investors can reach out via telephone or through email. Reaching out to professionals who understand the complexities of securities law could be a vital step for impacted shareholders.
Frequently Asked Questions
What is the purpose of the class action?
The class action seeks to recover losses for investors who purchased shares of Applied Therapeutics during the time when alleged securities fraud occurred.
How can I join the class action?
To join the class action, affected shareholders need to reach out to the law firm handling the case before the deadline to secure their participation as a possible lead plaintiff.
What does a Complete Response Letter (CRL) indicate?
A CRL signifies that the FDA has completed its review of a drug application but could not approve it in its current form due to identified deficiencies.
Are there any costs associated with participating?
Typically, there are no upfront costs to participate in a class action lawsuit, as fees are generally covered from the recovery amount if successful.
Why should I consider joining this class action?
Joining the class action may help recover lost investment capital if the lawsuit is successful, providing a collective avenue for affected shareholders to address grievances against the company.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.